Journal of Nutritional Sciences and Dietetics 2015. 1(3):127-133.

Association of body mass index with oxidative stress in patients with Type 2 diabetes: do apolipoprotein A-II -265T > C polymorphism alter this association?
Elham Zamani, Mahmoud Djalali, Mohammadreza Eshraghian, Gity Sotoudeh, Haleh Sadrzadeh-Yeganeh, Fariba Koohdani

Abstract


Background: To compare the oxidative stress (OS) factors in obese and non- obese subjects with Type 2 diabetes (T2D) and to evaluate the interaction between the apolipoprotein A-II (Apo A-II) - 265T > C polymorphism and body mass index (BMI) on OS factors.

Methods: In this comparative cross-sectional study, 21 diabetes centers in Tehran, Iran were studied. 180 patients with T2D were divided into two groups of 90 obese (BMI ≥ 30) and 90 non-obese (BMI < 30) with equal numbers of each genotypes of Apo A-II (TT = 30, CC = 30 and TC = 30). Superoxide dismutase (SOD) activity, total antioxidant capacity (TAC) and  8-isoprostane F2α concentration were compared between two groups obese and non-obese and between subjects with and without central obesity. Then, the  interaction between the Apo  A-II polymorphism and BMI on OS factors were analyzed by general linear model.

Results: After adjusting for confounding factors, it was observed that the mean of SOD activity and TAC were lower in the obese group than in the non-obese group (p < 0.050). The mean concentration of 8-isoprostane F2α was not statistically different between the two groups. Adjusting for BMI showed that the differences in the mean OS factors were not statistically significant between men and women with and without central obesity. It was also observed that the interaction between the Apo A-II polymorphism and BMI on OS factors were not significant.

Conclusion: OS level was the higher in obese subjects with T2D than non-obese one.  The  interaction  between  BMI  and  Apo  A-II  polymorphism  had  not  a significant effect on OS factors.


Keywords


Obesity; Apolipoprotein A-II; Type 2 diabetes; Oxidative stress

Full Text:

PDF

References


Sikaris KA. The clinical biochemistry of obesity.Clin Biochem Rev. 2004; 25(3): 165-81.

Racette SB, Deusinger SS, Deusinger RH.Obesity: overview of prevalence, etiology, and treatment. Phys Ther. 2003; 83(3): 276-88.

Fernández-Sánchez A, Madrigal-Santillán E, Bautista M, Esquivel-Soto J, Morales-González A, Esquivel-Chirino C, et al. Inflammation, oxidative stress, and obesity. Int J Mol Sci. 2011;12(5): 3117-32.

Corella D, Arnett DK, Tsai MY, Kabagambe EK, Peacock JM, Hixson JE, et al. The 256T > C> polymorphism in the apolipoprotein a-ii gene promoter is associated with body mass index and food intake in the genetics of lipid lowering drugs and diet network study. Clinical Chemistry. 2007;53(6): 1-9.

Stutzmann F, Cauchi S, Durand E, Calvacanti- Proenca C, Pigeyre M, Hartikainen AL, et al. Common genetic variation near MC4R is associated with eating behaviour patterns in European populations. Int J Obes (Lond). 2009;33(3): 373-8.

Corella D, Peloso G, Arnett DK, Demissie S, Cupples LA, Tucker K, et al. APOA2, dietary fat, and body mass index: replication of a gene-diet interaction in 3 independent populations. Arch Intern Med. 2009; 169(20): 1897-906.

Smith CE, Ordovas JM, Sanchez-Moreno C, Lee YC, Garaulet M. Apolipoprotein A-II polymorphism: relationships to behavioural and hormonal mediators of obesity. Int J Obes (Lond).2012; 36(1): 130-6.

Castellani LW, Navab M, van Lenten BJ, Hedrick CC, Hama SY, Goto AM, et al. Overexpression of apolipoprotein AII in transgenic mice converts high density lipoproteins to proinflammatory particles. J Clin Invest. 1997; 100(2): 464-74.

Ribas V, Sanchez-Quesada JL, Anton R, Camacho M, Julve J, Escola-Gil JC, et al. Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential. Circ Res. 2004; 95(8): 789-97.

Wang Y, Niimi M, Nishijima K, Waqar AB, Yu Y, Koike T, et al. Human apolipoprotein A-II protects against diet-induced atherosclerosis in transgenic rabbits. Arterioscler Thromb Vasc Biol. 2013; 33(2): 224-31.

American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care.2010; 33(Suppl 1): S62-S69.

Hammond KA, Litchford MD. Clinical: inflammation, physical, and functional assessments. In: Mahan L, Escott-Stump S, Raymond JL, Editors. Krause's food & the nutrition care process. Oxford, UK: Elsevier Health Sciences; 2012. p. 163-77.

Schaffer SW, Jong CJ, Mozaffari M. Role of oxidative stress in diabetes-mediated vascular dysfunction: unifying hypothesis of diabetes revisited. Vascul Pharmacol. 2012; 57(5-6): 139-49.

Vicentini J, Valentini J, Grotto D, Paniz C, Roehrs M, Brucker N, et al. Association among microalbuminuria and oxidative stress biomarkers in patients with type 2 diabetes. J Investig Med.2011; 59(4): 649-54.

Isogawa A, Yamakado M, Yano M, Shiba T.Serum superoxide dismutase activity correlates with the components of metabolic syndrome or carotid artery intima-media thickness. Diabetes Res Clin Pract. 2009; 86(3): 213-8.

Basiri MG, Sotoudeh G, Alvandi E, Djalali M, Eshraghian MR, Noorshahi N, et al. APOA2 -256T>C polymorphism interacts with saturated fatty acids intake to affect anthropometric and hormonal variables in type 2 diabetic patients.Genes Nutr. 2015; 10(3): 464.

Centers for Disease Control and Prevention.Overweight & obesity [Online]. [cited 2009]; Available from: URL:http://www.cdc.gov/obesity/

Aadahl M, Jorgensen T. Validation of a new self-report instrument for measuring physical activity. Med Sci Sports Exerc. 2003; 35(7): 1196-202.

Esmaillzadeh A, Mirmiran P, Azizi F. Whole- grain consumption and the metabolic syndrome: a favorable association in Tehranian adults. Eur J Clin Nutr. 2005; 59(3): 353-62.

Alvandi E, Koohdani F. Zip nucleic acid: a new reliable method to increase the melting temperature of real-time PCR probes. J Diabetes Metab Disord. 2014; 13(1): 26.

Kusano C, Ferrari B. Total antioxidant capacity: a biomarker in biomedical and nutritional studies. Journal of Cell and Molecular Biology. 2008;7(1): 1-15.

Corella D, Tai ES, Sorli JV, Chew SK, Coltell O, Sotos-Prieto M, et al. Association between the APOA2 promoter polymorphism and body weight in Mediterranean and Asian populations: replication of a gene-saturated fat interaction. Int J Obes (Lond). 2011; 35(5): 666-75.

Amirkhizi F, Siassi F, Minaie S, Djalali M, Rahimi A, Chamari M. Is obesity associated with increased plasma lipid peroxidation and oxidative stress in women? ARYA Atheroscler. 2007; 2(4):189-92.

Brown LA, Kerr CJ, Whiting P, Finer N, McEneny J, Ashton T. Oxidant stress in healthy normal-weight, overweight, and obese individuals. Obesity (Silver Spring). 2009; 17(3):460-6.

Chrysohoou C, Panagiotakos DB, Pitsavos C, Skoumas I, Papademetriou L, Economou M, et al. The implication of obesity on total antioxidant capacity in apparently healthy men and women: the ATTICA study. Nutr Metab Cardiovasc Dis.2007; 17(8): 590-7.

Nojima M, Sakauchi F, Mori M, Tamakoshi A, Ito Y, Watanabe Y, et al. Relationship of serum superoxide dismutase activity and lifestyle in healthy Japanese adults. Asian Pac J Cancer Prev.2009; 10(Suppl): 37-40.

Urakawa H, Katsuki A, Sumida Y, Gabazza EC, Murashima S, Morioka K, et al. Oxidative stress is associated with adiposity and insulin resistance in men. J Clin Endocrinol Metab.2003;88(10):4673-6.

Dambal SS, Indumati V, Kumari S. Role of oxidative stress in obesity with an insight into type II diabetes mellitus. Journal of Clinical and Diagnostic Research. 2011; 5(1): 52-4.

World Health Organization. Diabetes mellitus [Online].[cited 2015]; Available from: URL: http://who.int/mediacentre/factsheets/fs138/en/

Komosinska-Vassev K, Olczyk K, Olczyk P, Winsz-Szczotka K. Effects of metabolic control and vascular complications on indices of oxidative stress in type 2 diabetic patients. Diabetes Res Clin Pract. 2005; 68(3): 207-16.

Pasaoglu H, Sancak B, Bukan N. Lipid peroxidation and resistance to oxidation in patients with type 2 diabetes mellitus. Tohoku J Exp Med. 2004; 203(3): 211-8.

Fattman CL, Schaefer LM, Oury TD. Extracellular superoxide dismutase in biology and medicine. Free Radic Biol Med. 2003; 35(3): 236-56.

Fonseca-Alaniz MH, Takada J, Alonso-Vale MI, Lima FB. Adipose tissue as an endocrine organ: from theory to practice. J Pediatr (Rio J). 2007;83(5 Suppl): S192-S203.

Morrow JD. Is oxidant stress a connection between obesity and atherosclerosis? Arteriosclerosis, Thrombosis, and Vascular Biology. 2003; 23: 368-70.

Lastra G, Manrique CM, Hayden MR. The role of beta-cell dysfunction in the cardiometabolic syndrome. J Cardiometab Syndr. 2006; 1(1): 41-6.

Bouloumie A, Marumo T, Lafontan M, Busse R.Leptin induces oxidative stress in human endothelial cells. FASEB J. 1999; 13(10): 1231-8.

Beltowski J, Wojcicka G, Jamroz A. Leptin decreases plasma paraoxonase 1 (PON1) activity and induces oxidative stress: the possible novel mechanism for proatherogenic effect of chronic hyperleptinemia. Atherosclerosis. 2003; 170(1):21-9.

Khan NI, Naz L, Yasmeen G. Obesity: an independent risk factor for systemic oxidative stress. Pak J Pharm Sci. 2006; 19(1): 62-5.

Taheri E, Djalali M, Saedisomeolia A, Malekshahi- Moghadam A, Djazayeri A, Qorbani M. The relationship between the activates of antioxidant enzymes in red blood cells and body mass index in Iranian type 2 diabetes and healthy subjects. J Diabetes Metab Disord. 2012; 11: 3.

Takada D, Emi M, Ezura Y, Nobe Y, Kawamura K, Iino Y, et al. Interaction between the LDL- receptor gene bearing a novel mutation and a variant in the apolipoprotein A-II promoter: molecular study in a 1135-member familial hypercholesterolemia kindred. J Hum Genet.2002; 47(12): 656-64.

van't Hooft FM, Ruotolo G, Boquist S, de Faire U, Eggertsen G, Hamsten A. Human evidence that the apolipoprotein a-II gene is implicated in visceral fat accumulation and metabolism of triglyceride-rich lipoproteins. Circulation. 2001;104(11): 1223-8.

Yamashita J, Iwamura C, Sasaki T, Mitsumori K, Ohshima K, Hada K, et al. Apolipoprotein A-II suppressed concanavalin A-induced hepatitis via the inhibition of CD4 T cell function. J Immunol. 2011; 186(6): 3410-20.


Refbacks

  • There are currently no refbacks.


 
Creative Commons Attribution-NonCommercial 3.0

This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.